Howard Hughes Medical Institute’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.51M Buy
23,851
+23,491
+6,525% +$3.82M 0.84% 19
2025
Q4
$70.2K Buy
360
+5
+1% +$1.19K 0.04% 28
2025
Q3
$99.8K Buy
355
+5
+1% +$1.27K 0.06% 18
2025
Q2
$76.5K Buy
+350
New +$56.5K 0.03% 23
2014
Q4
Sell
-13,077
Closed -$501K 188
2014
Q3
$501K Buy
13,077
+6,664
+104% +$270K 0.11% 76
2014
Q2
$260K Buy
+6,413
New +$264K 0.04% 82

Other funds holding ORCL

Howard Hughes Medical Institute's ORCL Position: Q1 2026 in Review

Howard Hughes Medical Institute increased its Oracle (ORCL) stake by 6,525% in Q1 2026, buying an estimated $3.82M and bringing the position to 23,851 shares worth $3.51M. The position accounts for 0.84% of the portfolio, ranked #19.

Howard Hughes Medical Institute first reported a position in ORCL in Q2 2014 and has held it in 6 quarters since. 3,475 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Howard Hughes Medical Institute held 23,851 shares of Oracle worth $3.51M as of Q1 2026.
  • Howard Hughes Medical Institute bought 23,491 Oracle shares in Q1 2026, an estimated $3.82M.
  • Oracle made up 0.84% of Howard Hughes Medical Institute's portfolio in Q1 2026, its #19 holding.
  • Howard Hughes Medical Institute first reported a position in Oracle in Q2 2014 and has held it in 6 quarters since.
  • 3,475 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.